期刊
NATURE MEDICINE
卷 19, 期 7, 页码 879-888出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.3253
关键词
-
资金
- NIAID NIH HHS [U19 AI088778, R56 AI060389, AI060389, AI88778, R01 AI060389] Funding Source: Medline
- NIDA NIH HHS [R01 DA024563, DA024563] Funding Source: Medline
Hepatitis C virus (HCV) is a global public health problem involving chronic infection of the liver, which can cause liver disease and is linked with liver cancer. Viral innate immune evasion strategies and human genetic determinants underlie the transition of acute HCV infection to viral persistence and the support of chronic infection. Host genetic factors, such as sequence polymorphisms in IFNL3, a gene in the host interferon system, can influence both the outcome of the infection and the response to antiviral therapy. Recent insights into how HCV regulates innate immune signaling within the liver reveal a complex interaction of patient genetic background with viral and host factors of innate immune triggering and control that imparts the outcome of HCV infection and immunity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据